Skip to main content
. 2022 Apr 18;11(4):e1388. doi: 10.1002/cti2.1388

Figure 4.

Figure 4

Neutralising capacity over time. Neutralising capacity (a) 3 months (n = 227) and (b) 7 months (n = 312) post‐BNT162b2 vaccination and (c) 3 months (n = 100) post‐ChAdOx1 nCoV‐19 vaccination against ten SARS‐CoV‐2 variants including the wild‐type (WT), B.1.1.7 (Alpha), B.1.351 (Beta), B.1.526.1 (New York), B.1.617 (India), B.1.617.1 (Kappa), B.1.617.2 (Delta), B.1.617.3 (India), P.1 (Gamma) and P.2 (Zeta) variants. Dots represent GMTs, and bars represent 95% CI. Dark‐coloured dots represent SARS‐CoV‐2‐recovered vaccinees, and light‐coloured dots represent SARS‐CoV‐2‐naïve vaccinees.